Calendar-Period Variation in the Association Between Documented Complete Rotavirus Vaccination and Laboratory-Confirmed Gastroenteritis: An 11-Year Test-Negative Study
Abstract
Background/Objectives: Rotavirus vaccines have been available in Türkiye as self-financed products since 2006, but nationally representative uptake data and long-term data on their association with laboratory-confirmed rotavirus gastroenteritis remain limited. We evaluated calendar-period variation in the association between documented complete rotavirus vaccination and laboratory-confirmed rotavirus gastroenteritis among children younger than 5 years. Methods: This retrospective test-negative study included children aged 0–59 months who underwent qualitative stool rotavirus antigen testing during clinically evaluated acute gastroenteritis at a tertiary hospital between January 2015 and June 2026. Cases were rotavirus-positive episodes and controls were rotavirus-negative episodes. The institutional vaccination registry identified documented completion of either the two-dose Rotarix or three-dose RotaTeq schedule before testing, it did not separately identify partial schedules. Cluster-robust logistic regression adjusted for age group, sex, treatment setting, calendar year, and test month. Results are reported as odds ratios (ORs) with 95% confidence intervals (CIs). Results: The analysis included 2788 episodes among 2242 children: 534 rotavirus-positive cases and 2254 test-negative controls. Documented complete vaccination was recorded in 81 cases (15.2%) and 539 controls (23.9%). The adjusted OR for rotavirus positivity was 0.47 (95% CI, 0.36–0.62) for episodes with…
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.